- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
-0.17| Last Update: 06/19/13 - 3:30 PM EDT |
| Volume: 2,493,407 |
| YTD Performance: 32.39% |
| Open: $34.58 |
| Previous Close: $34.54 |
| 52 Week Range: $20.49 - $35.02 |
| Oustanding Shares: 444,646,972 |
| Market Cap: 15,273,623,488 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.52 | $0.54 | $2.15 | $2.49 |
| Number of Analysts | 14 | 13 | 16 | 16 |
| High Estimate | $0.54 | $0.56 | $2.20 | $2.59 |
| Low Estimate | $0.46 | $0.50 | $1.91 | $2.35 |
| Prior Year | $0.41 | $0.42 | $1.91 | $2.15 |
| Growth Rate (Year over Year) | 26.13% | 29.49% | 12.37% | 16.07% |
Invesco downgraded at UBSShares of IVZ were downgraded to Neutral from Buy, said UBS. Progress toward margin target has been solid and is priced in. Price target goes to $35.
Invesco price target and estimates increased at CitiIVZ earnings estimates were increased as stronger cost controls are expected to lead to margin expansion, said Citigroup. Price target goes to $39.
Invesco added to TPL! at CitigroupIVZ was added to Top Picks Live! at Citigroup. $34 price target. Deep YTD underpeformance.
Invesco downgraded at BMOIVZ was downgraded from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $29 price target.
Invesco downgraded at Morgan StanleyIVZ was downgraded from Overweight to Equal-weight, Morgan Stanley said. $30 price target. Company lacks near-term catalysts.
Invesco numbers cut at CitigroupShares of IVZ now seen reaching $27.50, Citigroup said. Estimates also lowered as October AUM in line, but equities remain sluggish.
Invesco estimates, target raised at BMOShares of IVZ now seen reaching $28, according to BMO Capital. Estimates also increased, as the company is gaining market share.
Invesco estimates, target reduced at BMOIVZ estimates were cut through 2013, BMO Capital said. Company is hurt by lower market performance and currency headwinds. Outperform rating and new $27 price target.
Invesco numbers raised at CitigroupShares of IVZ now seen reaching $30, according to Citigroup. Estimates also increased as model efficacy climbs and risks dissipate. Buy rating.
Invesco estimates, target boosted at Credit SuisseShares of IVZ now seen reaching $26, according to Credit Suisse. Estimates also upped, as the company is carrying a lot of earnings momentum into the new year. Outperform rating.